Seeking Alpha

Bank of America upgrades Orexigen Therapeutics (OREX) to Buy with a lofty price objective of $7...

Bank of America upgrades Orexigen Therapeutics (OREX) to Buy with a lofty price objective of $7 as analysts with the firm identify attractive valuation and potential near-term catalysts. Shares +8.9% premarket.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|